Ultherapy Downtime and Recovery: What to Discuss
Returning to usual activities and recovering from treatment effects are different considerations after Ultherapy (MFU-V). Redness, swelling, tenderness, bruising or altered sensation can occur even when daily activities are possible. Plan aftercare and follow-up with the treating clinician.
Possible temporary effects
The US instructions for use describe these effects after face and neck treatment. Their duration varies by symptom and person. US instructions for use
| Effect | Recovery discussion |
|---|---|
| Redness or swelling | May be visible after treatment |
| Tenderness or bruising | Can persist after usual activities resume |
| Numbness, tingling or muscle weakness | Discuss new or worsening symptoms promptly with the treating clinician |
Questions about aftercare
| Topic | What to ask |
|---|---|
| Work, exercise and travel | Which activities should I adjust for my treatment area and symptoms? |
| Skincare and other procedures | When should I resume my products, makeup or other treatments? |
| Medicines and follow-up | Which medicines need review, whom should I contact, and when is follow-up? |
Ask for instructions suited to your treatment. Do not stop prescribed medicines on your own.
Assessing results separately from recovery
A retrospective MFU-V study assessed facial and neck outcomes at 90 and 180 days. Those observation points do not establish when every patient will see a result. Arrange a result review separately from any assessment of recovery symptoms.[2]
Frequently asked questions
Does returning to activities mean no recovery effects?
No. Being able to work or go out can coexist with redness, swelling, tenderness, bruising or altered sensation.
What should I ask my treating clinician about aftercare?
Ask about activity changes, skincare, medicines, symptoms that need assessment and the follow-up plan.
For an example of a clinic's written instructions, see Delight Dermatology's ultrasound-lifting aftercare sheet.
When to contact the clinic
Seek prompt clinical assessment for new facial weakness, movement asymmetry, significant or worsening numbness, spreading redness, worsening swelling, blistering or skin breakdown. Sudden facial droop, limb weakness or speech difficulty needs emergency assessment. Mild stable numbness can last several weeks, but should be discussed with the treating clinician.
Risks and contraindications
Redness, swelling, tenderness, bruising and altered sensation can occur. Postmarketing reports also include muscle weakness, burns, nodules and fat or volume loss; their frequency is uncertain. Discuss prior fillers and implants before treatment. In a 52-patient open-label trial across Fitzpatrick III–VI skin, the three reported adverse events resolved by day 90 without sequelae[1].
The US instructions for use list open wounds or lesions, severe or cystic acne, and active or metallic implants in the treatment area as contraindications. Pregnancy, breastfeeding and anticoagulant use have not been evaluated; defer treatment during pregnancy or breastfeeding and review medications with the prescriber. Do not stop prescribed medication yourself. Avoid treating directly over an existing keloid; a history of abnormal scarring requires assessment. Korean treatment must follow the labeling for the exact device used. The full set of candidacy criteria is laid out on the candidates and contraindications page.
References
- Harris MO, Sundaram HA. Safety of Microfocused Ultrasound With Visualization in Patients With Fitzpatrick Skin Phototypes III to VI. JAMA Facial Plast Surg. 2015;17(5):355-7.
- Fabi SG, Goldman MP. Retrospective evaluation of micro-focused ultrasound for lifting and tightening the face and neck. Dermatol Surg. 2014;40(5):569-75.
Medically reviewed by a Korean Board-Certified Dermatologist (AAD International Fellow · ASLMS member). Last reviewed 2026-07-11. Editorially updated 2026-10-18.